Peptide Drug May Prolong Brain Cancer Survival, Boost Chemotherapy (2 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

Peptide Drug May Prolong Brain Cancer Survival, Boost Chemotherapy (2 of 3)

Caption

Inhibition of the NFkB pathway by depletion of one of tis components, IKK2 (represented in red) in glioblastoma tumor cells (shown in green and yellow) resulted in slower tumor growth. This material relates to a paper that appeared in the Jan. 8, 2016, issue of Science, published by AAAS. The paper, by D. Friedmann-Morvinski of The Salk Institute for Biological Studies in La Jolla, Calif., and colleagues was titled, "Targeting NF-κB in glioblastoma: A therapeutic approach."

Credit

[Credit: Courtesy of Dinorah Friedmann-Morvinski]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.